ITMI20032175A1 - PHARMACEUTICAL FORMULATIONS OF DESTINED BISPHOSPHONATES - Google Patents

PHARMACEUTICAL FORMULATIONS OF DESTINED BISPHOSPHONATES

Info

Publication number
ITMI20032175A1
ITMI20032175A1 IT002175A ITMI20032175A ITMI20032175A1 IT MI20032175 A1 ITMI20032175 A1 IT MI20032175A1 IT 002175 A IT002175 A IT 002175A IT MI20032175 A ITMI20032175 A IT MI20032175A IT MI20032175 A1 ITMI20032175 A1 IT MI20032175A1
Authority
IT
Italy
Prior art keywords
bisphosphonates
destined
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
IT002175A
Other languages
Italian (it)
Inventor
Tiberio Bruzzese
Original Assignee
Tiberio Bruzzese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tiberio Bruzzese filed Critical Tiberio Bruzzese
Priority to IT002175A priority Critical patent/ITMI20032175A1/en
Priority to PCT/EP2004/012660 priority patent/WO2005044280A1/en
Publication of ITMI20032175A1 publication Critical patent/ITMI20032175A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
IT002175A 2003-11-11 2003-11-11 PHARMACEUTICAL FORMULATIONS OF DESTINED BISPHOSPHONATES ITMI20032175A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT002175A ITMI20032175A1 (en) 2003-11-11 2003-11-11 PHARMACEUTICAL FORMULATIONS OF DESTINED BISPHOSPHONATES
PCT/EP2004/012660 WO2005044280A1 (en) 2003-11-11 2004-11-09 Biphosphonate pharmaceutical formulations (water emulsion of lipids/phospholipids) and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002175A ITMI20032175A1 (en) 2003-11-11 2003-11-11 PHARMACEUTICAL FORMULATIONS OF DESTINED BISPHOSPHONATES

Publications (1)

Publication Number Publication Date
ITMI20032175A1 true ITMI20032175A1 (en) 2005-05-12

Family

ID=34566910

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002175A ITMI20032175A1 (en) 2003-11-11 2003-11-11 PHARMACEUTICAL FORMULATIONS OF DESTINED BISPHOSPHONATES

Country Status (2)

Country Link
IT (1) ITMI20032175A1 (en)
WO (1) WO2005044280A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080139513A1 (en) * 2006-09-26 2008-06-12 Novavax, Inc. Transdermal deliver of active agents
US20090118239A1 (en) * 2007-11-05 2009-05-07 Teva Pharmaceutical Industries Ltd. Amorphous and crystalline forms of ibandronate disodium
US8323687B2 (en) * 2008-03-18 2012-12-04 Aleksander Vladimirovich Dikovskiy Pharmaceutical composition for the prevention and treatment of bone tissue resorption of various etiology
EP2180003A1 (en) * 2008-10-21 2010-04-28 Zentiva, k.s. Preparation of ibandronate trisodium
IT1396937B1 (en) * 2009-11-26 2012-12-20 Bruzzese FORMULATIONS OF BISPHOSPHONATES AND VITAMIN D SUITABLE FOR INTERMITTENT ADMINISTRATION BY INTRAMUSCULAR AND SUBCUTANEOUS
ITMI20120393A1 (en) * 2012-03-14 2013-09-15 Tiberio Bruzzese AQUEOUS FORMULATIONS OF BISPHOSPHONATES, VITAMIN D AND BENZYL ALCOHOL SUITABLE FOR INTRAMUSCULAR OR SUBCUTANEOUS USE
WO2016155809A1 (en) * 2015-03-31 2016-10-06 Biontech Rna Pharmaceuticals Gmbh Lipid particle formulations for delivery of rna and water-soluble therapeutically effective compounds to a target cell

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703691D0 (en) * 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
US5932563A (en) * 1998-10-23 1999-08-03 Ohio State Research Foundation Methods for treating spinal cord injury
BR0110316A (en) * 2000-04-07 2005-01-18 Regents For The University Of Unique Zwitterionic Phospholipid and Bisphosphonate Compositions and Use of the Compositions as Bisphosphate Delivery Systems with Reduced Gly Toxicity
US6468559B1 (en) * 2000-04-28 2002-10-22 Lipocine, Inc. Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods

Also Published As

Publication number Publication date
WO2005044280A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
PT1501534E (en) PHARMACEUTICAL FORMULATIONS
NO20033556L (en) Pharmaceutical Formulations
CY2018005I1 (en) ORAL PHARMACEUTICAL FORMS OF CLANTRIVINE
DK1545467T3 (en) Solid pharmaceutical formulations comprising telmisartan
NO20033384L (en) Pharmaceutical Formulation
DE60307677D1 (en) DISPERSIBLE PHARMACEUTICAL COMPOSITIONS
IS8309A (en) formulations
NO20033785L (en) Pharmaceutical formulation
MX266708B (en) FORMULATIONS OF PANTOPRAZOL MICROPARTICLES.
IL180031A0 (en) Stable pharmaceutical formulations of benzimidazole compounds
EE200300589A (en) Pharmaceutical compositions
DK1622612T3 (en) Pharmaceutical formulation of the sodium salt of telmitarsan
NO20035627D0 (en) Pharmaceutical formulation
NO20044722L (en) High dose of ibandronate formulation
DK1539089T3 (en) REDUCED AEROSOL-GENERATING FORMULATIONS
ITMI20032175A1 (en) PHARMACEUTICAL FORMULATIONS OF DESTINED BISPHOSPHONATES
ITMI20031994A1 (en) PROCEDURE FOR THE PREPARATION OF FLUDARABINA FOSFATO
ITMI20030018A1 (en) PROCEDURE FOR THE PREPARATION OF SINGLE COMPOUNDS
NO20044164L (en) Pharmaceutical compositions
GB0328040D0 (en) Pharmaceutical uses of bisphosphonates
ITMI20030019A1 (en) PROCEDURE FOR THE PREPARATION OF SINGLE COMPOUNDS
ITRM20030053A1 (en) ASSOCIATION OF ANTIABETIC DRUGS.
ITTO20020406A1 (en) FORMULATIONS OF BISPHOSPHONATES FOR INJECTABLE USE.
ITMI20020639A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING AS ACTIVE INGREDIENT 1-ISOPROPIL-3 ° (4-M-TOLUIDINO-3-PRIDIL) SULFONIL! -UREA
NO20041236L (en) Pharmaceutical Formulation